Dynamic Prediction Model for Patients with Unresectable Biliary Malignancies Receiving Systemic Chemotherapy Combined with Immunotherapy: a Multicenter, Observational Study

RecruitingOBSERVATIONAL
Enrollment

332

Participants

Timeline

Start Date

January 31, 2025

Primary Completion Date

March 31, 2026

Study Completion Date

May 31, 2026

Conditions
Unresectable Biliary Tract CancerDynamic Prediction ModelImmunotherapy
Interventions
DRUG

Systemic chemotherapy combined with immunotherapy

The electronic medical record system was used to collect patients' basic information and treatment plan information, including treatment plan, administration cycle, administration date, administration dose, frequency, number of cycles, efficacy, adverse reactions, etc.

Trial Locations (2)

Unknown

RECRUITING

Zhongda Hospital,, Nanjing

ACTIVE_NOT_RECRUITING

Zhongda Hospital, Nanjing

All Listed Sponsors
collaborator

Eastern Hepatobiliary Surgery Hospital

OTHER

collaborator

The First Affiliated Hospital of Zhengzhou University

OTHER

collaborator

The Third Affiliated Hospital of Soochow University

OTHER

collaborator

Jiangsu Cancer Institute & Hospital

OTHER

collaborator

The First Affiliated Hospital, University of Science and Technology of China

OTHER

collaborator

Zhejiang Cancer Hospital

OTHER

collaborator

Shanghai Zhongshan Hospital

OTHER

collaborator

Yunnan Cancer Hospital

OTHER

lead

Zhongda Hospital

OTHER